These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The role of cytokines in hemolytic transfusion reactions. Davenport RD Immunol Invest; 1995; 24(1-2):319-31. PubMed ID: 7713593 [TBL] [Abstract][Full Text] [Related]
3. Cytokine roles in hemolytic and nonhemolytic transfusion reactions. Davenport RD; Kunkel SL Transfus Med Rev; 1994 Jul; 8(3):157-68. PubMed ID: 8081078 [No Abstract] [Full Text] [Related]
4. Cytokine production in IgG-mediated red cell incompatibility. Davenport RD; Burdick M; Moore SA; Kunkel SL Transfusion; 1993 Jan; 33(1):19-24. PubMed ID: 8424264 [TBL] [Abstract][Full Text] [Related]
5. Cytokines and erythrocyte incompatibility. Davenport R Curr Opin Hematol; 1994 Nov; 1(6):452-6. PubMed ID: 9371322 [TBL] [Abstract][Full Text] [Related]
6. Hemolysis from ABO Incompatibility. Simmons DP; Savage WJ Hematol Oncol Clin North Am; 2015 Jun; 29(3):429-43. PubMed ID: 26043383 [TBL] [Abstract][Full Text] [Related]
7. Monocyte chemoattractant protein production in red cell incompatibility. Davenport RD; Burdick M; Strieter RM; Kunkel SL Transfusion; 1994 Jan; 34(1):16-9. PubMed ID: 8273123 [TBL] [Abstract][Full Text] [Related]
8. Hemolytic and pseudo-hemolytic transfusion reactions: an overview of the hemolytic transfusion reactions and the clinical conditions that mimic them. Beauregard P; Blajchman MA Transfus Med Rev; 1994 Jul; 8(3):184-99. PubMed ID: 8081080 [No Abstract] [Full Text] [Related]
9. Cytokine storm in a mouse model of IgG-mediated hemolytic transfusion reactions. Hod EA; Cadwell CM; Liepkalns JS; Zimring JC; Sokol SA; Schirmer DA; Jhang J; Spitalnik SL Blood; 2008 Aug; 112(3):891-4. PubMed ID: 18483395 [TBL] [Abstract][Full Text] [Related]
10. Risks of hemolysis due to anti-A and anti-B caused by the transfusion of blood or blood components containing ABO-incompatible plasma. Berséus O; Boman K; Nessen SC; Westerberg LA Transfusion; 2013 Jan; 53 Suppl 1():114S-123S. PubMed ID: 23301963 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of A plasma for incompatible patients. Olsen G; Passwater M; Huggins M; Mukhtar F; Pelletier P Transfusion; 2021 Feb; 61(2):375-378. PubMed ID: 33219552 [TBL] [Abstract][Full Text] [Related]
12. Transfusion of cryopreserved human red blood cells into healthy humans is associated with rapid extravascular hemolysis without a proinflammatory cytokine response. Hult A; Malm C; Oldenborg PA Transfusion; 2013 Jan; 53(1):28-33. PubMed ID: 22612879 [TBL] [Abstract][Full Text] [Related]
13. Erythropoietin in the treatment of delayed immune hemolysis of a major ABO-incompatible bone marrow transplant. López J; Steegmann JL; Pérez G; Otero MJ; Berberana M; Cámara R; Lamana M; Fernández Villalta MJ; Fernández-Rañada JM Am J Hematol; 1994 Mar; 45(3):237-9. PubMed ID: 8296795 [TBL] [Abstract][Full Text] [Related]
14. HEMOLYTIC TRANSFUSION REACTIONS AND ACUTE RENAL FAILURE. BLUEMLE LW Trans Am Clin Climatol Assoc; 1962; 74():201-10. PubMed ID: 14044610 [No Abstract] [Full Text] [Related]
15. Interleukin-8 production in red blood cell incompatibility. Davenport RD; Strieter RM; Standiford TJ; Kunkel SL Blood; 1990 Dec; 76(12):2439-42. PubMed ID: 1702325 [TBL] [Abstract][Full Text] [Related]
16. Impact of Unsaturated Fatty Acids on Cytokine-Driven Endothelial Cell Dysfunction. Trommer S; Leimert A; Bucher M; Schumann J Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29258201 [TBL] [Abstract][Full Text] [Related]
18. Risk factors for hemolytic transfusion reactions resulting from ABO and minor red cell antigen incompatibility: From mislabeled samples to stem cell transplant and sickle cell disease. Gehrie EA; Savani BN; Booth GS Blood Rev; 2021 Jan; 45():100719. PubMed ID: 32561028 [TBL] [Abstract][Full Text] [Related]
19. Intervertebral disc cells produce tumor necrosis factor alpha, interleukin-1beta, and monocyte chemoattractant protein-1 immediately after herniation: an experimental study using a new hernia model. Yoshida M; Nakamura T; Sei A; Kikuchi T; Takagi K; Matsukawa A Spine (Phila Pa 1976); 2005 Jan; 30(1):55-61. PubMed ID: 15626982 [TBL] [Abstract][Full Text] [Related]
20. Anti-HI can cause a severe delayed hemolytic transfusion reaction with hyperhemolysis in sickle cell disease patients. Ibanez C; Habibi A; Mekontso-Dessap A; Chadebech P; Chami B; Bierling P; Galactéros F; Rieux C; Nataf J; Bartolucci P; Peyrard T; Pirenne F Transfusion; 2016 Jul; 56(7):1828-33. PubMed ID: 27145018 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]